HOME >> MEDICINE >> NEWS
Developer of anthrax quick test finds similar test for strep throat

Orlando, FL -- The culprit in bacterial streptococcus pharyngitis, or strep throat, can be vicious. Ask a parent who suspects their child has caught the virus, or the family of 29 Texans, including nine children, who died in 1997 after the bacteria manifested itself into a flesh eating disease. This virulent disorder used to cause physicians to order patients to immediately start taking antibiotics even when a bacterial origin had not been established.

But taking antibiotics when not needed reduces the curative effects of antibiotics. That is why physicians applauded the introduction of the Rapid Streptococcal Antigen Test or the "rapid strep" test. Research indicates that this test, which takes about 20 minutes, is just as accurate as the much slower culture analysis. (If the rapid test is not clearly negative and symptoms exist, a doctor may also perform a regular culture.)

Advocates claim the rapid test is 80 to 90 percent sensitive in detecting group A beta-hemolytic streptococcus in throat swabs and 90 to 95 percent specific in eliminating streptococcal infection as a consideration in rapid test-negative patients. Detection of streptococci by rapid antigen tests or throat culture has consistently been shown to be a cost-effective strategy in the management of sore throat, independent of the issues surrounding antibiotic overuse.

But the leader of a team that developed a rapid test for anthrax exposure has completed an assessment of various testing procedures used in the rapid test and found the results wanting. He suggests that rapid antigen testing lacks sensitivity, negative results require a back-up culture and that its sensitivity may be declining. One alternative is rRNA (ribosomal ribonucleic acid) testing which has enhanced sensitivity but is still not as effective as a culture. His conclusion is that assessing PCR (polymerase chain reaction) using the same principle and diagnostic equipment in a proposed test for anthr
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
407-685-4215
American Association for Clinical Chemistry
29-Jul-2002


Page: 1 2 3

Related medicine news :

1. Study models impact of anthrax vaccine
2. Initiative yields effective methods for anthrax detection; RAMP and MIDI, Inc., methods approved
3. Prescriptions for antibiotics to prevent anthrax uncommon after the 2001 anthrax attacks
4. Needle-free anthrax vaccine shows promise in animal studies
5. New type of anthrax vaccine moves into larger-scale trial at Saint Louis University
6. Phase II trial of anthrax vaccine to begin
7. Rensselaer researcher receives $2.1 million grant to develop treatment for anthrax
8. BioSecurity 2003 to draw top experts in anthrax, smallpox, SARS
9. University of Illinois at Chicago receives $15.7 million grant to stop anthrax
10. Mouse study gives new view of anthrax toxin
11. HHS announces contracts for developing a new anthrax vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Developer anthrax quick test finds similar test for strep throat

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: